本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Regulus Therapeutics Inc

7.97
+0.02000.25%
成交量:42.77万
成交额:338.73万
市值:5.52亿
市盈率:-11.02
高:7.98
开:7.91
低:7.88
收:7.95
数据加载中...
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/17

SEC问询函

Form CORRESP - Correspondence
2024/03/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/20

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/06

SEC问询函

Form CORRESP - Correspondence
2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/06/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/23

重要事件披露

Form 8-K - Current report